Robust positive control of tumour growth using angiogenic inhibition

被引:0
|
作者
Homayounzade, Mohamadreza [1 ]
Homayounzadeh, Maryam [1 ,2 ]
Khooban, Mohammad Hassan [1 ,3 ]
机构
[1] Fasa Univ, Mech Engn Dept, Fasa, Iran
[2] Aarhus Univ, Aarhus, Denmark
[3] Aarhus Univ, Elect Engn Dept, Aarhus, Denmark
关键词
biocontrol; cancer; control theory; feedback; Lyapunov methods; nonlinear control systems; robust control; AUTOMATIC REGULATION; MODEL; DESIGN;
D O I
10.1049/syb2.12076
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In practice, many physical systems, including physiological ones, can be considered whose input can take only positive quantities. However, most of the conventional control methods do not support the positivity of the main input data to the system. Furthermore, the parameters of these systems, similar to other non-linear systems, are either not accurately identified or may change over time. Therefore, it is reasonable to design a controller that is robust against system uncertainties. A robust positive-input control method is proposed for the automatic treatment of targeted anti-angiogenic therapy implementing a recently published tumour growth model based on experiments conducted on mouse models. The backstepping (BS) approach is applied to design the positive input controller using sensory data of tumour volume as feedback. Unlike previous studies, the proposed controller only requires the measurement of tumour volume and does not require the measurement of inhibitor level. The exponential stability of the controlled system is proved mathematically using the Lyapunov theorem. As a result, the convergence rate of the tumour volume can be controlled, which is an important issue in cancer treatment. Moreover, the robustness of the system against parametric uncertainties is verified mathematically using the Lyapunov theorem. The real-time simulation results-based (OPAL-RT) and comparisons with previous studies confirm the theoretical findings and effectiveness of the proposed method. A robust positive input control method is proposed for the automatic treatment of targeted anti-angiogenic molecular therapy using a recently published tumour growth model based on mice experiments. The exponential stability of the controlled system and bounded input bounded output stability of the system in the presence of uncertainties are proved mathematically using the Lyapunov theorem. The actual input of the system is controlled without the need to extend the system model and generate dummy input to ensure the positivity of the input.image
引用
收藏
页码:288 / 301
页数:14
相关论文
共 50 条
  • [31] Inhibition of angiogenesis and murine tumour growth by laminarin sulphate
    Hoffman, R
    Paper, DH
    Donaldson, J
    Vogl, H
    BRITISH JOURNAL OF CANCER, 1996, 73 (10) : 1183 - 1186
  • [32] Growth retardation and tumour inhibition by BRCA1
    Holt, JT
    Thompson, ME
    Szabo, C
    RobinsonBenion, C
    Arteaga, CL
    King, MC
    Jensen, RA
    NATURE GENETICS, 1996, 12 (03) : 298 - 302
  • [33] Analysis and design of motion control systems with positive force/torque feedback using robust control methods
    Lin, HM
    McInroy, JE
    Hamann, JC
    IEEE TRANSACTIONS ON CONTROL SYSTEMS TECHNOLOGY, 2005, 13 (05) : 752 - 759
  • [34] Inhibition of activation of dsRNA-dependent protein kinase and tumour growth inhibition
    Helen L. Eley
    Pria S. McDonald
    Steven T. Russell
    Michael J. Tisdale
    Cancer Chemotherapy and Pharmacology, 2009, 63
  • [35] Positive Real Method for Robust Control Problems
    Liu Kang-Zhi
    Yao Yu
    PROCEEDINGS OF THE 31ST CHINESE CONTROL CONFERENCE, 2012, : 2715 - 2720
  • [36] Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor
    Voisine, P
    Bianchi, C
    Ruel, M
    Malik, T
    Rosinberg, A
    Feng, J
    Khan, TA
    Xu, SH
    Sandmeyer, J
    Laham, RJ
    Sellke, FW
    SURGERY, 2004, 136 (02) : 407 - 415
  • [37] Inhibition of activation of dsRNA-dependent protein kinase and tumour growth inhibition
    Eley, Helen L.
    McDonald, Pria S.
    Russell, Steven T.
    Tisdale, Michael J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (04) : 651 - 659
  • [38] Antineoplastic impact of leishmanial sphingolipid in tumour growth with regulation of angiogenic event and inflammatory response
    Subhadip Das
    Nabanita Chatterjee
    Dipayan Bose
    Somenath Banerjee
    Tarun Jha
    Krishna Das Saha
    Apoptosis, 2015, 20 : 869 - 882
  • [39] Differential Growth Inhibition of Cerebral Metastases by Anti-angiogenic Compounds
    Martin, Daniel K.
    Uckermann, Ortrud
    Bertram, Aiko
    Liebner, Corina
    Hendruschk, Sandy
    Sitoci-Ficici, Kerim Hakan
    Schackert, Gabriele
    Lord, Edith M.
    Temme, Achim
    Kirsch, Matthias
    ANTICANCER RESEARCH, 2014, 34 (07) : 3293 - 3302
  • [40] Antineoplastic impact of leishmanial sphingolipid in tumour growth with regulation of angiogenic event and inflammatory response
    Das, Subhadip
    Chatterjee, Nabanita
    Bose, Dipayan
    Banerjee, Somenath
    Jha, Tarun
    Das Saha, Krishna
    APOPTOSIS, 2015, 20 (06) : 869 - 882